We are live on ! Find out more
PAHC icon

Phibro Animal Health

149 hedge funds and large institutions have $265M invested in Phibro Animal Health in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

1% more funds holding

Funds holding: 148149 (+1)

2% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 54

3.63% less ownership

Funds ownership: 101.62%97.99% (-3.6%)

33% less capital invested

Capital invested by funds: $395M → $265M (-$130M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $199K

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
53
Reduced
54
Closed
21
Calls
Puts
$199K
Net Calls
-$199K
Net Calls Change
-$199K
Name Holding Trade Value Shares
Change
Change in
Stake
GCP
76
GSA Capital Partners
United Kingdom
$303K -$149K -8,620 -27%
WG
77
Winton Group
United Kingdom
$281K +$65K +3,765 +22%
Thrivent Financial for Lutherans
78
Thrivent Financial for Lutherans
Minnesota
$279K +$18K +1,043 +5%
State of Wisconsin Investment Board
79
State of Wisconsin Investment Board
Wisconsin
$275K -$19.4K -1,125 -5%
Canada Life
80
Canada Life
Manitoba, Canada
$258K -$27K -1,564 -7%
JF
81
Jump Financial
Illinois
$250K +$325K +18,800 New
COPPSERS
82
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$246K -$173 -10 -0.1%
AIMCA
83
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$246K +$320K +18,545 New
Citigroup
84
Citigroup
New York
$239K -$3.26K -189 -1%
FHB
85
First Hawaiian Bank
Hawaii
$235K
YCM
86
Yousif Capital Management
Michigan
$220K -$6.58K -381 -2%
Comerica Bank
87
Comerica Bank
Texas
$218K -$32.1K -1,859 -11%
NSEDCP
88
NJ State Employees Deferred Compensation Plan
New Jersey
$213K
CS
89
Credit Suisse
Switzerland
$211K +$1.93K +112 +0.7%
Barclays
90
Barclays
United Kingdom
$208K -$175K -10,112 -39%
II
91
Inspire Investing
Idaho
$207K +$75.5K +4,373 +39%
TPSF
92
Texas Permanent School Fund
Texas
$192K -$1.66K -96 -0.7%
SOADOR
93
State of Alaska Department of Revenue
Alaska
$186K -$22.7K -1,314 -9%
Bank of America
94
Bank of America
North Carolina
$180K -$1.74M -100,821 -88%
UBS AM
95
UBS AM
Illinois
$174K
T. Rowe Price Associates
96
T. Rowe Price Associates
Maryland
$171K +$21.4K +1,239 +11%
HSBC Holdings
97
HSBC Holdings
United Kingdom
$159K -$67.9K -3,934 -25%
MIM
98
MetLife Investment Management
New Jersey
$158K
AIG
99
American International Group
New York
$148K +$2.11K +122 +1%
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$142K +$8.77K +508 +5%

PAHC Hedge Fund Activity: Q3 2022 in Review

149 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2022, worth a combined $265M — down 33% from $395M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PAHC positions and 21 closed out — a net gain of 3 holders — while 53 added to existing stakes and 54 trimmed.

The largest buyer was Millennium Management, adding an estimated $10.8M. The largest seller was Fiduciary Management Inc, exiting entirely with an estimated $17M sold.

  • 149 institutional investors held Phibro Animal Health (PAHC) as of Q3 2022, up from 148 in Q2 2022.
  • Funds reported $265M of Phibro Animal Health stock for Q3 2022, down 33% quarter-over-quarter.
  • 24 funds opened new Phibro Animal Health positions in Q3 2022 and 21 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q3 2022 was Millennium Management, an estimated $10.8M added.
  • The largest Phibro Animal Health seller in Q3 2022 was Fiduciary Management Inc, an estimated $17M sold.

Based on aggregated 13F filings for Q3 2022.